Richard Dagher

Richard Dagher

Auto-generated profile, based on publicly available information

Richard Dagher

From the Department of Neuroradiology (R.D., H.A.Q., D.K., S.A., M.W.) and Department of Imaging Physics (P.S., B.A.T., P.H., H.-L.L.), The University of Texas MD Anderson Cancer Center

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2024 in Journal of Neuroimaging
Verified
Journal Article
Closed access
RDRichard Dagher
Richard Dagher
BOBurak Berksu Ozkara
Burak Berksu Ozkara
MKMert Karabacak
Mert Karabacak
SDSamir A. Dagher
Samir A. Dagher
ERElijah Isaac Rumbaut
Elijah Isaac Rumbaut
MWMax Wintermark
Max Wintermark

11 January 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
RDRichard Dagher
Richard Dagher
MGMona Gad
Mona Gad
PSPaloma da Silva de Santana
Paloma da Silva de Santana
MSMohammad Amin Sadeghi
Mohammad Amin Sadeghi
SYSelome F. Yewedalsew
Selome F. Yewedalsew
LLLicia P. Luna
Licia P. Luna

12 August 2024 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
RDRichard Dagher
Richard Dagher
PAParisa Arjmand
Parisa Arjmand
BOBurak Berksu Ozkara
Burak Berksu Ozkara
MRMahla Radmard
Mahla Radmard
MGMona Gad
Mona Gad
LLLicia P. Luna
Licia P. Luna
BACKGROUND: While the diagnosis of frontotemporal dementia (FTD) is based mostly on clinical features, [18F]-FDG PET has been investigated as a potential imaging golden standard in ambiguous cases, with arterial spin labeling (ASL) MRI gaining recent interest. PURPOSE: The purpose of this study is to conduct a systematic review and meta-analysis on the diagnostic performance of ASL MRI in FTD patients and compare it to that of [18F]-FDG PET. DATA SOURCES: A systematic search of PubMed, Scopus and EMBASE was conducted until March 13, 2024. STUDY SELECTION: Inclusion criteria were: original articles, patients with FTD and/or its variants, use of ASL MR perfusion imaging with or without [18F]-FDG PET, presence of sufficient diagnostic performance data. Exclusion criteria were: meeting abstracts, comments, summaries, protocols, letters and guidelines, longitudinal studies, overlapping cohorts. DATA ANALYSIS: The quality of eligible studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) for [18F]-FDG PET and ASL MRI were calculated, and a summary receiver operating characteristic curve was plotted. DATA SYNTHESIS: Seven eligible studies were identified, which included a total of 102 FTD patients. Aside from some of the studies showing at worst an unclear risk of bias in patient selection, index test, flow and timing, all studies showed low risk of bias and applicability concerns in all categories. Data from 4 studies was included in our meta-analysis for ASL MRI and 3 studies for [18F]-FDG PET. Pooled sensitivity, specificity and DOR were 0.70 (95% CI: 0.59-0.79), 0.81 (95% CI: 0.71-0.88) and 8.00 (95% CI: 3.74-17.13) for ASL MRI, and 0.88 (95% CI: 0.71-0.96), 0.89 (95% CI: 0.43-0.99) and 47.18 (95% CI: 10.77-206.75) for [18F]-FDG PET. LIMITATIONS: The number of studies was relatively small, with a small sample size. The studies used different scanning protocols as well as a mix of diagnostic metrics, all of which might have introduced heterogeneity in the data. CONCLUSIONS: While ASL MRI performed worse than [18F]-FDG PET in the diagnosis of FTD, it exhibited a decent diagnostic performance to justify its further investigation as a quicker and more convenient alternative. ABBREVIATIONS: 3DPCASL, 3D pseudocontinuous ASL; AD, Alzheimer’s disease; ASL, arterial spin labeling; AUC, area under the curve; CI, confidence interval; DOR, diagnostic odds ratio; FN, false negative; FP, false positive; FTD, frontotemporal dementia; LE, limbic encephalitis; NLR, negative likelihood ratio; PASL, pulsed ASL; PLD, post-label delay; PLR, positive likelihood ratio; PRISMA, PSP, progressive supranuclear palsy; Preferred Reporting Items for Systematic Reviews and Meta-Analysis; SROC, summary receiver operative characteristic; TN, true negative; TP, true positive; QUADAS-2, Quality Assessment of Diagnostic Accuracy Studies-2.

10 February 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
RDRichard Dagher
Richard Dagher
PAParisa Arjmand
Parisa Arjmand
DSDaniel A. Stevens
Daniel A. Stevens
MWMax Wintermark
Max Wintermark
HSHaris Iqbal Sair
Haris Iqbal Sair
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
BACKGROUND AND PURPOSE: PTSD has been linked to an increased risk of cognitive impairment and dementia, with neuroinflammation, metabolic dysfunction, and neuropathological markers such as beta-amyloid and tau implicated as potential mechanisms. However, the roles of altered functional connectivity and amyloid deposition as biomarkers in the progression of cognitive impairment among PTSD patients remain unclear, with limited and often conflicting evidence from existing neuroimaging studies. This study examines these neuroimaging markers in PTSD patients with and without cognitive impairment to better understand the neurobiological pathways contributing to cognitive decline in PTSD. MATERIALS AND METHODS: Data were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Department of Defense (DOD) ADNI databases. A cohort of 178 age-matched male subjects was divided into four groups: PTSD with cognitive impairment (CI) (PTSD-CI); PTSD and cognitively normal (CN) (PTSD-CN); non-PTSD (NPTSD with CI (NPTSD-CI); and NPTSD and CN (NPTSD-CN). All subjects underwent resting-state functional MRI and amyloid PET imaging, with PTSD diagnosis and CI confirmed through clinical assessments. Functional connectivity was analyzed using the CONN Toolbox, and amyloid burden was quantified via standardized uptake value ratios. Analyses controlled for demographic and genetic factors, including age, education, APOE4 status, and depression. RESULTS: Compared to the NPTSD-CN group, the PTSD-CI group showed significantly increased amyloid uptake in the temporal and parietal lobes, with corresponding functional connectivity increase between the bilateral temporal lobes and parietal operculum. In contrast, PTSD-CN patients exhibited no significant amyloid increase but showed increased connectivity between the salience network, postcentral gyri and sensorimotor areas, and decreased connectivity between the sensorimotor network and anterior cingulate cortex. These distinct patterns suggest differing neurobiological profiles between PTSD-CI and PTSD-CN patients. CONCLUSIONS: The findings suggest that elevated amyloid and altered connectivity patterns are associated with CI in PTSD, particularly in the temporal and parietal regions. In contrast, PTSD without cognitive decline was associated with functional connectivity changes in salience and sensorimotor networks but no increased amyloid deposition. This study underscores the importance of neuroimaging biomarkers in understanding PTSD-related cognitive decline and suggests avenues for further investigation into the mechanistic pathways involved. ABBREVIATIONS: ACC = anterior division of the cingulate gyrus; ADAS-Cog = Alzheimer’s Disease Assessment Scale-Cognitive; CAPS = Clinician-Administered PTSD Scale; PTSD = post-traumatic stress disorder; CI = cognitively impaired; CN = cognitively normal; ECog = Everyday Cognition; GDS = Geriatric Depression Scale; MoCA = Montreal Cognitive Assessment; NPTSD = non-PTSD.

30 November 2025 in Journal of Neuroimaging
Verified
Journal Article
Closed access
ABAnushree Burade
Anushree Burade
DLDhairya A Lakhani
Dhairya A Lakhani
RDRichard Dagher
Richard Dagher
JAJohn Anosh
John Anosh
HSHaris I. Sair
Haris I. Sair
LLLicia P. Luna
Licia P. Luna

21 November 2024 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SDSamir A. Dagher
Samir A. Dagher
KLKim O. Learned
Kim O. Learned
RDRichard Dagher
Richard Dagher
JWJennifer Rui Wang
Jennifer Rui Wang
XZXiao Zhao
Xiao Zhao
AKAlexander M. Khalaf
Alexander M. Khalaf
BACKGROUND AND PURPOSE: Neoadjuvant BRAF-directed therapy and immunotherapy followed by surgery improves survival in patients with BRAFV600E-mutant anaplastic thyroid carcinoma (ATC), more so in those who have complete ATC pathologic response. This study assesses the ability of FDG-PET to non-invasively detect residual high-risk pathologies including ATC and poorly differentiated thyroid carcinoma (PDTC) in the preoperative setting. MATERIALS AND METHODS: This retrospective, single-center study included consecutive BRAFV600E-mutant ATC patients treated with at least 30 days of neoadjuvant BRAF-directed therapy and who underwent FDG-PET/CT within 30 days prior to surgery. The highest pathologic grade observed for every head and neck lesion resected was recorded. Each lesion on pre-operative PET/CT was retrospectively characterized. The primary endpoint was to contrast the standardized uptake normalized by lean body mass (SULmax) for lesions with residual high-risk (ATC, PDTC) versus low-risk pathologies (papillary thyroid carcinoma, negative). An optimal SULmax threshold was then identified using a ROC analysis, and the ability of this threshold to non-invasively and preoperatively risk-stratify patients by overall survival was then evaluated with a Kaplan-Meier plot. RESULTS: 30 patients (mean age 66.5±9.0; 17 males) were included in this study, with 94 surgically sampled lesions. Of these lesions, 57 (60.6%) were low-risk (39 negative, 18 papillary thyroid carcinoma) and 37 (39.4%) were high-risk (29 ATC, 8 PDTC). FDG uptake was higher for high-risk compared to low-risk pathologies: median SULmax 5.01 [IQR 2.81 – 10.95] versus 1.29 [IQR 1.06 – 3.1] (P<.001, Mann-Whitney U test). The sensitivity, specificity, and accuracy for detecting high-risk pathologies at the optimal threshold of SULmax ≥ 2.75 were 0.784 [95% CI 0.628–0.886], 0.702 [95% CI 0.573–0.805], and 0.734 [95% CI 0.637–0.813], respectively. Patients with at least 1 high-risk lesion identified with the aforementioned cut-off had a worse prognosis compared to patients without high-risk lesions in the head and neck: median OS for the former group was 259 days and was not attained for the latter (P=.038, log-rank test). CONCLUSIONS: Preoperative FDG-PET non-invasively identifies lesions with residual high-risk pathologies following neoadjuvant BRAF-directed targeted therapy and immunotherapy for BRAF-mutated ATC. FDG-PET avidity may serve as an early prognostic marker which correlates with residual high-risk pathology in BRAF-mutated ATC following neoadjuvant therapy. ABBREVIATIONS: ATC = anaplastic thyroid carcinoma; IQR = interquartile range; OS = overall survival; PDTC = poorly differentiated thyroid carcinoma; PTC = papillary thyroid carcinoma; ROC = receiver operating characteristic; SUL= standardized uptake value normalized by lean body mass.